Jetbest Corporation (4741) AI Stock Analysis

Jetbest Corporation

(TPEx:4741)

Select Model

Rating:61Neutral

Price Target:TWD 60.00▼(-0.66% Downside)

Action:initiatedcoverage

Date:11/10/26

The score is primarily constrained by weakening operating performance, declining margins, and deteriorating cash generation. A strong, low-debt balance sheet and favorable technical momentum provide support, but the high P/E and low dividend yield limit the overall attractiveness.

Positive Factors

Low LeverageJetbest’s low and stable leverage provides financial resilience and preserves borrowing capacity if investment or working-capital needs increase. A large equity base relative to assets also reduces balance-sheet stress, giving the company greater flexibility through weaker operating conditions.

Negative Factors

Revenue and Margin ContractionRepeated revenue declines and sharply compressed margins weaken the stability of Jetbest’s earnings base. Lower operating profitability leaves less room to absorb cost pressure or reinvest, while sustained weakness could make future earnings more volatile and reduce returns on the existing asset base.

Jetbest Corporation (4741) vs. SPDR S&P 500 ETF (SPY)

Market Cap: TWD 2.04B
Dividend Yield: 0.50%
Average Volume (3M): 578.22K
Price to Earnings (P/E): 42.9
Beta (1Y): 0.60
Revenue Growth: 5.77%
EPS Growth: 157.11%
Country: TW
Employees: 98
Sector: General
Sector Strength: 55
Industry: Chemicals - Specialty

Jetbest Corporation Business Overview & Revenue Model

Company Description

Jetbest Corporation is a global enterprise focused on the research, development, manufacturing, and distribution of inkjet printing products, serving markets in Taiwan and worldwide. Their extensive product line encompasses a diverse array of inks, i...

Jetbest Corporation Financial Statement Overview

Summary

Strong balance sheet with low debt and substantial equity is offset by declining revenue, sharply compressed margins, weak ROE, and deteriorating cash-flow conversion.

Income Statement

35Negative

Balance Sheet

82Very Positive

Cash Flow

60Neutral

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	525.23M	484.90M	590.08M	648.57M	724.51M	630.20M
Gross Profit	172.41M	131.25M	202.78M	200.86M	178.10M	159.10M
EBITDA	78.77M	51.94M	125.60M	116.48M	104.14M	76.89M
Net Income	42.04M	10.11M	65.26M	66.20M	55.13M	29.67M
Balance Sheet
Total Assets	1.15B	1.12B	1.14B	1.17B	1.17B	1.17B
Cash, Cash Equivalents and Short-Term Investments	364.67M	359.75M	375.86M	382.89M	278.91M	230.28M
Total Debt	98.33M	97.45M	83.88M	95.59M	92.63M	121.10M
Total Liabilities	219.38M	197.70M	189.80M	223.71M	235.16M	260.23M
Stockholders Equity	928.48M	910.55M	939.97M	933.96M	913.61M	885.31M
Cash Flow
Free Cash Flow	20.02M	9.23M	72.10M	145.02M	100.42M	-38.15M
Operating Cash Flow	38.39M	36.66M	110.01M	156.67M	103.46M	57.13M
Investing Cash Flow	-114.22M	-123.56M	-40.86M	-9.36M	-2.83M	-91.86M
Financing Cash Flow	-33.11M	-25.65M	-76.15M	-41.52M	-53.38M	4.92M

Jetbest Corporation Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TW:4741 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TW:6527	73Outperform	TWD 1.86B	12.15	―	3.98%	-1.23%	10.20%
TW:4138	68Neutral	TWD 2.15B	15.66	―	7.75%	-1.10%	-16.90%
TW:4116	62Neutral	TWD 1.82B	2.38	―	4.91%	3.85%	786.65%
TW:4741	61Neutral	TWD 2.09B	42.95	―	0.50%	5.77%	157.11%
TW:4175	60Neutral	TWD 2.09B	13.16	―	6.00%	2.49%	5.18%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TW:4747	53Neutral	TWD 1.60B	-23.25	―	3.32%	4.56%	-172.55%

* General Sector Average

Performance Comparison

TW:4741 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TW:4741	Jetbest Corporation	60.40	38.85	180.29%
TW:4116	BenQ Medical Technology Corp.	40.70	-2.63	-6.06%
TW:4138	Dynamic Medical Technologies Inc.	54.20	-5.23	-8.80%
TW:4175	MedFirst Healthcare Services, Inc. (TW)	50.00	-3.90	-7.23%
TW:4747	Johnson Chemical Pharmaceutical Works Co., Ltd.	15.80	-15.43	-49.41%
TW:6527	Crystalvue Medical Co Ltd	72.90	-5.53	-7.05%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026

Jetbest Corporation AI Stock Analysis